Back
Atlas Lithium Vs. Corcept Therapeutics Industry Stock Comparison
Sell
47
ATLX
Atlas Lithium
Last Price:
7.46
Seasonality Move:
333.63%
Buy
86
CORT
Corcept Therapeutics
Last Price:
57.76
Seasonality Move:
4.71%
Sell
47
Atlas Lithium (ATLX)
is a Sell
Is Atlas Lithium a Buy, Sell or Hold?
- The current Atlas Lithium [ATLX] share price is $8.09. The Score for ATLX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- ATLX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
86
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $59.12. The Score for CORT is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ATLX Stock Price Chart
What is Atlas Lithium's stock price today?
-
The Atlas Lithium share price today is $8.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATLX is experiencing slight selling pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $59.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
ATLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 44.59 | Sell |
Chaikin Money Flow: | -13196 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.28 - 9.44) | Sell |
Bollinger Bands (100): | (7.84 - 11.22) | Sell |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.33 | Buy |
Relative Strength Index (14 RSI): | 78.53 | Buy |
Chaikin Money Flow: | 99396 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.14 - 52.96) | Buy |
Bollinger Bands (100): | (31.8 - 46.2) | Buy |
ATLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9 | Sell |
20-day SMA: | 8.66 | Sell |
50-day SMA: | 8.38 | Sell |
200-day SMA: | 12.66 | Sell |
8-day EMA: | 8.77 | Sell |
20-day EMA: | 8.67 | Sell |
50-day EMA: | 8.76 | Sell |
200-day EMA: | 12.58 | Sell |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.25 | Buy |
20-day SMA: | 49.96 | Buy |
50-day SMA: | 44.55 | Buy |
200-day SMA: | 32.18 | Buy |
8-day EMA: | 54.41 | Buy |
20-day EMA: | 50.72 | Buy |
50-day EMA: | 45.72 | Buy |
200-day EMA: | 35.55 | Buy |
Atlas Lithium Earnings Growth & ATLX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.82 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $4.35 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Atlas Lithium Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |